Navigation Links
No-nose bicycle saddles improve penile sensation and erectile function in bicycling police officers
Date:8/7/2008

ul intervention for bicycling police officers alleviating pressure to the groin and improving penis health. Different saddle designs may require some re-learning of 'how to ride a bicycle,' but the health benefits to having unrestricted vascular flow to and from the penis and less penile numbness is self-evident."

Dr. Irwin Goldstein, Director, Sexual Medicine, Alvarado Hospital, San Diego C.A., and editor-in-chief of The Journal of Sexual Medicine, wrote an accompanying editorial entitled "The A, B, C's of The Journal of Sexual Medicine: Awareness, Bicycle Seats, and Choices".

"For the first time, we have a prospective study of healthy policemen riding bikes on the job, using wider, no-nose bike saddles for 6 months. Not only did their sensation improve, their erectile function also improved. Changing saddles changed physiology. This is a landmark study for our field that that is important for future riders, and modification of lifestyle showing improvement without any active treatment."


'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Project Tsunami Report Proves the Power of Bicycles
2. Raleigh Dentist to Bicycle Across North Carolina to Raise Oral Cancer Awareness
3. Cooper Aerobics Center and KGS Bikes Team Up to Give Cyclists World-Class Testing, Training and Bicycle Fitting
4. Vision restoration therapy shown to improve brain activity in brain injured patients
5. Broad-based group of physicians calls for improvement in stroke treatment
6. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
7. Pill box organizers increase HIV patients adherence and improve viral suppression
8. Treating depression may improve recovery of heart rate variability following coronary syndromes
9. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
10. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
11. Exercise and yoga improves quality of life in women with early-stage breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...t risk may not be accurate in some cases , ...ies, from the United States and the Netherlands, q...shed Framingham Risk Score in predicting heart dis... score, based on findings of a decades-long study ... assess risk on the basis of seven factors: age, g...
(Date:1/8/2009)...re-USNewswire/ -- Today, the National Hospice and ...tional leadership organizations issued a consensus...e and protection of the Medicare Hospice Benefit. ...s unified message about end-of-life care are the A...cine, Hospice and Palliative Nurses Association, N...
(Date:1/8/2009)...anizations offers five action steps to improve res...wire/ -- Despite the recent three-hour cease fires...s to residents of the Palestinian territory, upwar...ean water and medical help. U.S.-based internation...egion see this arrangement to allow sporadic deliv...
(Date:1/8/2009)...urface of cancer cells are keys to the development...ing the spread of certain types of cancers called ...n and lung, among others. Armed with a new two-ye...Research, an Illinois-based philanthropic foundati...nd her co-workers at the Moores Cancer Center at t...
Breaking Medicine News(10 mins):Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2
... as a measure for weight reduction may have the po...of the most common procedures to control morbid ob...e size of the stomach and allows the food to pass ...gether with psychological and behavioral support, ...
...e disease of the substantia nigra ,an area in the ... and its symptoms documented in 1817 by the Britis... biochemical changes in the brain of patients were...re identified only recently, others still remain a...
...who had long earlier published their findings on s...ving ADHD, have come up with the results from the ... association between the two. The follow up data ...ticipants of the original study who had snored reg...
...al Agency for Research on Cancer (IARC) in Lyon, F...kers who are exposed to chronic low doses of radia...cer. This is the largest study ever conducted in 1...rkers. It was estimated that the chronic exposure ...
Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2
(Date:1/8/2009)..., Mass. and COLUMBUS, Ohio, Jan. 8 ...prietary nucleic acid assays, today announced that...al Quantitative Assay are complete. , , Under ...linearity, specificity and reproducibility and rob...termined. The data obtain agreed with internally g...
(Date:1/7/2009)...Tenn., Jan. 7 Scientist... a high likelihood of relapse in children with acu...archers caution that further research is needed to... or IKAROS, lead to leukemia relapse, the findin...nostic tests to assess the risk of treatment failu...
(Date:1/7/2009)...Several Products in Development Based On Osteotech...ate Natural BioRegeneration; FDA Filing Anticipate...an. 7 Osteotech, Inc. ...of biologic products for regenerative healing, ann...cal trial for its DuraTech(TM) BioRegeneration Mat...
(Date:1/6/2009)...xpands on Successful Results from prior U.S., U.K....wire/ -- Vital Therapies, Inc. (VTI), a developmen...ounced patient enrollment has begun for a randomiz...al that will study the Extracorporeal Liver Assist...ute Liver Failure (ALF) under three protocols. The...
Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 1University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 2SEIU Endorses Anderson Perea and Perea in Fresno 7229 1SEIU Endorses Anderson Perea and Perea in Fresno 7229 2FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3
...--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therape...lication,of data from a pivotal Phase III clinical... tablets in the June 2007 issue of the,Journal of ... Drug,Administration (FDA) on May 30, 2007. Critic...rtner Dey, L.P. (DEY), expects to,begin marketing ...
...ted at EULAR Confirms Efficacy with Either Every,T... June 2007 - 7:00 am CET - New pivotal data,(RAPID...ongress of,Rheumatology (EULAR) show that Cimzia (...anti-TNF, combined with methotrexate,therapy has a...s,and symptoms of active rheumatoid arthritis (RA)...
Other Medicine Technology:Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications.
DyNA Quant™ 200 is a fixed wavelength fluorometer for 365 nm excitation and 460 nm emission. The spectral characteristics are specifically designed for the detection of double-stranded DNA using
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates.
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C
Medicine Products: